Two Old Meds and a DOAC a Bust in COVID-19: The ACT Trials Two Old Meds and a DOAC a Bust in COVID-19: The ACT Trials
It ' s ' the end of the story for colchicine in COVID-19, ' an expert said. In addition, aspirin does not help outpatients with COVID and a low-dose oral anticoagulant does not improve inpatient outcomes.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Cardiology News Source Type: news
More News: Allergy | Allergy & Immunology | Aspirin | Cardiology | Colchicine | Colcrys | COVID-19 | Heart